Results 131 to 140 of about 3,169,439 (400)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

Humoral response to low molecular weight antigens of Mycobacterium tuberculosis by tuberculosis patients and contacts

open access: yesBrazilian Journal of Medical and Biological Research, 2005
Much effort has been devoted to the identification of immunologically important antigens of Mycobacterium tuberculosis and to the combination of target antigens to which antibodies from serum of tuberculous patients could react specifically.
Beck S.T.   +3 more
doaj  

Identificación de antígenos de quistes y trofozoítos de aislamientos colombianos de Giardia duodenalis reconocidos por IgA.

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2003
Se conoce poco acerca del papel de la IgA en la respuesta inmune de la giardiosis. El propósito de este trabajo fue identificar los antígenos estimuladores de la producción de IgA anti-Giardia duodenalis de aislamientos colombianos del parásito.
Rosana Natalia Olmos   +6 more
doaj   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

A systematic approach to quantitative Western blot analysis.

open access: yesAnalytical Biochemistry, 2020
Lakshmi Pillai-Kastoori   +2 more
semanticscholar   +1 more source

Use of a Western blot technique for the serodiagnosis of glanders

open access: yesBMC Veterinary Research, 2011
BackgroundThe in vivo diagnosis of glanders relies on the highly sensitive complement fixation test (CFT). Frequently observed false positive results are troublesome for veterinary authorities and cause financial losses to animal owners.
M. Elschner   +12 more
semanticscholar   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy